Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 2

2(33.3%)

Phase 3

1(16.7%)

Phase 1

1(16.7%)

6Total

N/A(2)

Phase 2(2)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05955924Phase 3Recruiting

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

Role: collaborator

NCT04585295Not ApplicableCompleted

The Effects of Pre-Loaded Betaine Supplementation on Thermoregulation and Exercise Metabolism in the Heat

Role: collaborator

NCT03769285Phase 2Unknown

Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial

Role: collaborator

NCT02002130Phase 1Completed

The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes

Role: collaborator

NCT03384095Phase 2Withdrawn

Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias

Role: collaborator

NCT02143817Not ApplicableCompleted

Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition

Role: collaborator

All 6 trials loaded